Online resources and coaching helped people seek genetic testing for cancer

Interventions combined information resources, motivational messaging to encourage eligible individuals to consider genetic testing

11:00 PM

Author | Nicole Fawcett

Three people stand arm in arm with backs to camera studying a wall of family mementos
Genetic testing can reveal cancer risk for the whole family. PHOTO CREDIT: Erica Bass

About 10% of cancers are linked to an inherited genetic variant, but as few as 1 in 15 cancer patients eligible for genetic testing complete it. 

 

One barrier to testing: Lack of knowledge. 

 

In a new study from researchers at the University of Michigan Rogel Cancer Center, an online resource and phone-based coaching both helped increase rates of genetic testing, suggesting that innovative ways to deliver information combined with motivational messaging could help move the needle. 

 

“Many barriers exist to genetic testing, including access, cost, privacy concerns and fear. Scalable strategies are needed to overcome these barriers and better facilitate genetic testing,” said senior study author Elena Stoffel, M.D., M.P.H., Clinical Professor of Internal Medicine/Gastroenterology at Michigan Medicine and Director of the Cancer Genetics Clinic at the Rogel Cancer Center. The grant was co-led by Jennifer J. Griggs, M.D., M.P.H., and Ken Resnicow, Ph.D. 

 

Candidates for genetic evaluation

The study engaged 793 adults from across Michigan who met clinical criteria for genetic evaluation based on their personal or family history of cancer. Participants were randomized to receive phone based health coaching, a self directed digital intervention or usual care. The two interventions included education about genetics and motivational interviewing concepts. 

 

Overall, 5% of participants completed genetic testing after six months and 10% completed testing after a year. Those who received either intervention were more likely to complete testing or to report that they intended to seek testing, compared to those receiving usual care. 

 

Results are published in JAMA Network Open. 

 

“We were able to move the needle, enabling some people in this study to complete genetic testing. We had hoped uptake of testing would be higher, but this highlights that there are a lot of barriers to accessing genetics and cancer prevention services. Even if people have the knowledge to decide this is something they want to do, there’s still a gap in getting them to make an appointment or talk to their doctor,” said lead study author Sarah Austin, M.S., C.G.C., Clinical Assistant Professor of Genetic Medicine at Michigan Medicine. 

 

Follow up plan 

The researchers followed up with participants at six months and a year, but Austin suspects that a longer time window may be needed to determine the real impact of the interventions, as people may require more time to make a decision about genetic testing and arrange clinical follow up.  

 

The team also noted that future approaches must be tailored to individuals. While some people will respond to information delivered online or through videos, others may prefer a one-on-one phone call and coaching.  

 

People who test positive for a genetic variant associated with increased cancer risk may be able to receive specialized cancer screening or surveillance to detect cancer sooner, or treatments to prevent cancer. For people already diagnosed with cancer, genetic testing could guide treatment choices. 

 

Improving identification 

The study, called the Michigan Genetic Hereditary Testing (MiGHT) trial, was one of several program grants from the National Cancer Institute designed to improve identification and care of individuals with genetic susceptibility to cancer. As results from the other projects are coming out, a theme is emerging: more work is needed to reach everyone eligible for cancer genetic testing. Investigators across projects are coming together to discuss research findings, pool their knowledge and shape future plans. 

 

“It’s not just about bridging the knowledge gap, but also addressing access, referral pathways and other barriers to help people get tested more easily,” Austin said. 

 

Additional authors: Emerson Delacroix, John D. Rice, Erika Keoppe, Elizabeth Rizzo, Erika N. Hanson, Liliana Arida-Moody, Shayna Weiner, Sarah T. Hawley, Wendy R. Uhlmann, J. Scott Roberts, Versha Pleasant, Katrina R. Ellis 

 

Funding: National Cancer Institute grants U01CA232827-05 and P30CA046592 

 

This work was supported by these Rogel Cancer Center Shared Resources: Cancer Health Communications 

 

 


More Articles About:

Rogel Cancer Center Cancer: Cancer Types Pancreatic cancer Cancer Research Cancer and Genetics Genetic Testing
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Sarah Austin

Sarah Austin, MS, CGC

Clinical Assistant Professor

Elena Martinez Stoffel MD

Elena Stoffel, MD, MPH

Clinical Professor

Related

Breast cancer graphics
Health Lab

How Hereditary Genetic Testing Results Impact Breast Cancer Treatment

Breast cancer patients who test positive for an inherited genetic mutation, such as having the BRCA1 or BRCA2 gene, may be receiving treatment based on future cancer risk, rather than guideline approved treatments for their diagnosed cancers, study finds.
Health Lab

Older Adults Have High Interest in Genetic Testing — and Some Reservations

More than 1 in 10 people ages 50 to 64 have had genetic tests ordered by a doctor or ordered them directly, a new survey finds. Others say they’re interested, but many have concerns.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Computer screens and microscope pictured in a laboratory setting.
Health Lab

Understanding family history key to early detection of pancreatic cancer

How genetic testing and family history help identify individuals at high risk for pancreatic cancer, enabling earlier screening and better treatment outcomes.
Michael Powers pictured here holding a fish he caught as he stands in a boat. He struggled with pancreatitis for several decades and found answers at University of Michigan Health.
Health Lab

Patient with rare form of diabetes finds answers in genetic testing, clinical trials

Discover how genetic testing and a groundbreaking clinical trial helped one man overcome rare hyperchylomicronemia, high triglycerides, and pancreatitis.
Group of men smiling in a field
News Release

How have diagnostic and treatment decisions for prostate cancer changed in recent years?

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis by University of Michigan Rogel Cancer Center researchers, indicates a shift toward surveillance in response to concerns of overdiagnosis and overtreatment that have hindered screening in the recent past.
Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
Family with mom and dad and three kids sitting on a park bench, dad's arms extended around the family.
Health Lab

Intuition pushed mom to keep checking for breast cancer

Michigan mom had no reason to suspect cancer. But instinct nudged her to find out for sure — and carried her through challenging treatments to remission.